Journal of Antimicrobial Chemotherapy (1983) 12, 515-518
© 1983 The British Society for Antimicrobial Chemotherapy
research-article |
Activity of trimethoprim (TMP), sulphamethoxazole (SMX) and the combination against Bacteroides fragilis group isolates
Infectious Disease Unit, Department of Medicine, University of Vermont College of Medicine Burlington, Vermont 05405, U.S.A
accepted 27 May 1983
The in-vitro efficacy of trimethoprim/sulphamethoxazole (TMP/SMX) was tested against 59 isolates belonging to the Bacteroides fragilis group of bacteria and was shown to be dependent upon the inoculum size. With an inoculum of 3 x 105 colony forming units (cfu), 98% of these isolates were susceptible to the combination, whereas with a higher inoculum of 106 cfu, 88% were susceptible. None of the isolates were susceptible to less than 2 mg/l of TMP, whereas 57 (97%) were susceptible to SMX at the lower inoculum and 21 (36%) at the higher inoculum. These data indicate that TMP/SMX has moderate activity against organisms of the Bact. fragilis group when tested at an inoculum of 106 cfu.